{
  "id": "cluster_32_doc2",
  "content": "Network memo from 08/2023 highlights increased referrals to Midwestern Liver Institute for Wilson's disease cases. Claims data shows 72% approval rate for WD-883 protocols, with denials primarily due to incomplete metabolic panels. Pharmacy coordinator Tyson Reece (tr@mwli.org) will implement new tracking system for zinc acetate prescriptions.",
  "metadata": {
    "format": "insurance_memo"
  }
}